Skip to main content Skip to main navigation menu Skip to site footer
Bleeding, Thrombosis and Vascular Biology

Editor-in-Chief: Giovanni de Gaetano, Italy | eISSN: 2785-5309

  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Archives
  • Copyright
  • Special Issues
    • Overview
  • Register
  • Login
  • Search
  • Contacts
  • News
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Pathways for lower extremity superficial vein thrombosis management in an academic medical center

    Gisoo Imani, Aaron Wilson, Sara Vazquez, Daniel M. Witt
    24-03-2025
    https://doi.org/10.4081/btvb.2025.155
    175
    PDF: 36
  • Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results The Apidulcis study

    Gualtiero Palareti, Paolo Prandoni, Cristina Legnani, Emilia Antonucci, Serena Zorzi, Alberto Tosetto, Lorenza Bertù, Sophie Testa, Vittorio Pengo, Walter Ageno, Ida Martinelli, Benilde Cosmi, Eugenio Bucherini, Daniela Poli
    22-03-2022
    https://doi.org/10.4081/btvb.2022.10
    1045
    PDF: 330
    APPENDIX: 67
  • Cancer complicated by thrombosis and thrombocytopenia: still a therapeutic dilemma

    Yishi Tan, Marc Carrier, Nicola Curry, Michael Desborough, Kathryn Musgrave, Marie Scully, Tzu-Fei Wang, Mari Thomas, Simon J. Stanworth
    16-05-2024
    https://doi.org/10.4081/btvb.2024.115
    671
    PDF: 210
  • Major bleedings in mechanical prosthetic heart valves patients on Vitamin K antagonist treatment. Data from the PLECTRUM Study

    Daniela Poli, Emilia Antonucci, Gualtiero Palareti, Roberto Facchinetti, Pietro Falco, Giuseppina Serricchio, Teresa Lerede, Lucilla Masciocco, Paolo Gresele, Sophie Testa
    27-07-2022
    https://doi.org/10.4081/btvb.2022.34
    4574
    PDF: 387
    Supplementary Files: 115
  • Comments on “Safe and effective anticoagulation use: case studies in anticoagulation stewardship”

    Marco Marietta, Giancarlo Castaman
    27-05-2025
    https://doi.org/10.4081/btvb.2025.180
    390
    PDF: 132
  • Stroke in women: anticoagulation in a complicated puzzle

    Francesco Marongiu, Elvira Grandone, Silvia Marongiu, Antonella Mameli, Doris Barcellona
    26-08-2024
    https://doi.org/10.4081/btvb.2024.137
    1075
    PDF: 283
  • Descriptive analysis of patients positive for anti-phospholipid antibodies included in two Italian registries

    Vittorio Pengo, Luca Sarti, Emilia Antonucci, Stefania Di Agostino, Elisa Bison, Gentian Denas, Daniela Poli, Pier Luigi Meroni, Roberto Gerli, Antonella Radice, Gualtiero Palareti, on behalf of FIRMA group and START collaborators
    12-10-2023
    https://doi.org/10.4081/btvb.2023.92
    779
    PDF: 219
  • Safety and efficacy of treatment with vitamin K antagonists in patients managed in a network of anticoagulation services or as routine general care

    Gianfranco De Girolamo, Luca Sarti, Sonia Cecoli, Karin Bonora, Chiara Ajolfi, Francesco Bellelli, Valeria Coluccio, Gualtiero Palareti, Marco Marietta
    15-04-2022
    https://doi.org/10.4081/btvb.2022.9
    653
    PDF: 211
    Supplementary Files: 68
  • Management of anticoagulation in atrial fibrillation patients in Italy: insight from the Atrial Fibrillation-Survey on Anticoagulated Patients Register (AF-START)

    Daniela Poli, Walter Ageno, Emilia Antonucci, Salvatore Bradamante, Eugenio Bucherini, Paolo Chiarugi, Antonio Chistolini, Benilde Cosmi, Anna Falanga, Antonio Insana, Domenico Lione, Rosa Maria Lombardi, Giuseppe Malcangi, Rossella Marcucci, Giuliana Martini, Lucilla Masciocco, Carmelo Paparo, Daniele Pastori, Simona Pedrini, Vittorio Pengo, Pasquale Pignatelli, Andrea Toma, Sophie Testa, Gualtiero Palareti
    27-06-2023
    https://doi.org/10.4081/btvb.2023.84
    1232
    PDF: 280
    Supplementary File: 151
  • The new era of anticoagulation: factor XI and XII inhibitors

    Domenico Prisco, Irene Mattioli, Raffaele De Caterina, Alessandra Bettiol
    07-06-2023
    https://doi.org/10.4081/btvb.2023.76
    2133
    PDF: 857
  • Thrombosis and hemostasis at the University of Padua: a reappraisal on the occasion of its 800th year of history

    Paolo Simioni, Vittorio Pengo, Paolo Prandoni
    07-11-2022
    https://doi.org/10.4081/btvb.2022.52
    1983
    PDF: 220
  • Distal deep vein thrombosis: is there a way out of this dark forest?

    Matteo Guarascio, Gerardo Nicola Pititto, Alessia Abenante, Marco Paolo Donadini
    04-09-2024
    https://doi.org/10.4081/btvb.2024.129
    697
    PDF: 219
  • Treatment of venous thromboembolism in pregnancy: findings from the RIETE Registry

    Paolo Prandoni, Franca Bilora, Raffaele Pesavento, Giorgina Salgueiro, Angeles Blanco-Molina, Raquel Lòpez-Reyes, Manuel Monreal, and the RIETE Investigators
    23-05-2022
    https://doi.org/10.4081/btvb.2022.28
    5192
    PDF: 448
    APPENDIX: 118
  • Attitude to clinical research among health professionals affiliated with the Italian Federation of Centers for the Diagnosis of Thrombotic Disorders and the Surveillance of the Antithrombotic Therapies (FCSA)

    Daniela Poli, Riccardo Tartaglia, Doris Barcellona , Paolo Bucciarelli , Antonio Ciampa, Elvira Grandone, Giuseppe Malcangi, Giuseppe Rescigno, Vincenzo Toschi, Sophie Testa, Alessandro Squizzato
    21-03-2023
    https://doi.org/10.4081/btvb.2023.59
    543
    PDF: 223
  • Polycythemia vera and management of the thrombotic risk: an update

    Massimo Franchini
    20-12-2023
    https://doi.org/10.4081/btvb.2023.102
    1852
    PDF: 273
  • New perspectives for prevention of the post-thrombotic syndrome

    Paolo Prandoni
    22-03-2022
    https://doi.org/10.4081/btvb.2022.20
    1450
    PDF: 441
  • Personalized bleeding risk assessment for atrial fibrillation patients on direct oral anticoagulants: the DOAC score

    Paolo Prandoni
    11-10-2023
    https://doi.org/10.4081/btvb.2023.97
    1488
    PDF: 224
  • A re-appraisal of thrombogenesis in COVID-19, seen as a multiple "Complex system"

    Sergio Coccheri
    24-10-2022
    https://doi.org/10.4081/btvb.2022.48
    1668
    PDF: 266
  • Risk of recurrent venous thromboembolism in cancer patients after discontinuation of anticoagulant therapy

    Gary E. Raskob
    16-05-2024
    https://doi.org/10.4081/btvb.2024.124
    547
    PDF: 216
  • Combined oral contraceptives and the risk of venous thromboembolism carriers of antithrombin, protein C or S deficiency: Sub-analysis of a prospective cohort study

    Daniela Tormene, Elena Campello, Chiara Simion, Anna Poretto, Paolo Prandoni, Paolo Simioni
    03-11-2022
    https://doi.org/10.4081/btvb.2022.42
    851
    PDF: 282
  • The introduction of the international normalized ratio as a breakthrough event in the history of thrombosis

    Armando Tripodi
    23-01-2025
    https://doi.org/10.4081/btvb.2025.169
    638
    PDF: 211
  • Management of atrial fibrillation: a practical and useful synopsis of last guidelines

    Gualtiero Palareti
    24-02-2025
    https://doi.org/10.4081/btvb.2025.168
    698
  • New drugs, old problems: immune checkpoint inhibitors and cancer-associated thrombosis

    Mehrie H. Patel, Alok A. Khorana
    16-05-2024
    https://doi.org/10.4081/btvb.2024.113
    509
    PDF: 237
  • How to manage antithrombotic treatments in thrombocytopenic patients with cancer. Comments on the European Haematology Association guidelines

    Anna Falanga, Hugo Ten Cate, Bianca Rocca
    27-01-2023
    https://doi.org/10.4081/btvb.2023.60
    658
    PDF: 298
  • Trends and updates on the epidemiology of cancer-associated thrombosis: a systematic review

    Ang Li, Emily Zhou
    16-05-2024
    https://doi.org/10.4081/btvb.2024.108
    694
    PDF: 266
  • Milvexian and other drugs targeting Factor XI: a new era of anticoagulation?

    Marco P. Donadini, Walter Ageno
    15-04-2022
    https://doi.org/10.4081/btvb.2022.22
    2007
    PDF: 528
  • Venous thromboembolism prophylaxis in orthopedic surgery: a narrative review

    Sarah Gallitto, Thomas C. Varkey, Jacob Lahti
    13-12-2024
    https://doi.org/10.4081/btvb.2024.131
    1088
    PDF: 178
1 - 27 of 27 items

authors

FOR AUTHORS
  • SUBMIT YOUR PAPER
  • Guide for Authors
  • Benefits for Authors
  • How to write a scientific paper
  • How to write a Review article

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to review

Categories

    • Contents
    • Original Articles
    • Reviews
    • Editorials
    • Case Reports
    • Letters
    • Correspondence
    • Abstract Book
    • Remembrances

indexing

INDEXING
  • DOAJ
  • Google Scholar
  • OpenAlex
  • Analytics

aice

Affiliated Scientific Society

Vol. 4 No. 2 (2025)
A commitment to global collaboration, welcoming international participation and advancing science for the benefit of patients
Pantep Angchaisuksiri et al.
18 April 2025
Vol. 4 No. 2 (2025)
2024 EACTS guidelines on perioperative medication in adult cardiac surgery: embracing precision medicine driven by strong evidence-based methodology
Bianca Rocca et al.
16 April 2025
Vol. 4 No. 2 (2025)
Comment on "Apixaban vs. aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or...
Vittorio Pengo
16 April 2025

Keywords

Bleeding, Thrombosis and Vascular Biology

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

eISSN: 2785-5309

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission
  • Guidelines For Authors

Our App Is Free For Anyone!

Themes by Openjournaltheme.com

© PAGEPress 2008-2025    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy